This is the authors' abstract. We don't add key points for this paper.
A 57-year-old male farmer with no known relevant medical history was referred to our outpatient dermatology clinic with a widespread eruption of 2 months' duration that started on the arms 3 days after occupational exposure to Glyfoon (Agrolac, Barcelona, Spain) containing glyphosate-isopropylamine salt. In addition, the patient had reportedly been exposed to other phytosanitary products at work. Physical examination showed eczematous lesions on the trunk, abdomen, and upper limbs (Figure 1A,B). A short 15-day course of prednisone 30 mg/day was prescribed, with complete clinical resolution by the time of the follow-up 4 weeks later. Two weeks after the end of oral corticosteroid treatment, a patch test was performed with the European comprehensive baseline series and the patient's own pesticides in different dilutions (1%–5%–10% aq) (Table 1) after careful consideration of their potential toxicity and consultation of specialists in toxicology. Patch occlusion was maintained for 48 h, and the tests were interpreted according to the recommendations of the International Contact Dermatitis Research Group. At both 48 (D2) and 96 h (D4), the patient showed a positive reaction (+) to Glyfoon 10% aq (Figure 1C). In contrast, a control group of 14 patients showed no reactions to Glyfoon 10% aq. Allergic contact dermatitis (ACD) due to glyphosateisopropylamine salt was diagnosed. The patient avoided the herbicide,
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Llamas‐Molina et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: